Ride-sharing giant Uber reported second-quarter financial results after markets closed Thursday. The company posted a net loss of $1.02 per share and $2.24 billion in revenue compared with consensus estimates t for a net…
Rocket Companies, parent of Rocket Mortgage and Quicken Loans, quietly entered the market on Thursday in its initial public offering.
Denali Therapeutics announced early Thursday that it would be progressing its Parkinson’s treatment into late-stage studies in collaboration with Biogen.
Plug Power released a better than expected second-quarter earnings report before the markets opened on Thursday, and shares shot up afterward.
Etsy shares sank early Thursday even though it reported better than expected second-quarter financial results after the markets closed on Wednesday.
Streaming video firm Roku reported a second-quarter net loss of $0.35 per share and $356 million in revenue compared to consensus estimates calling for a net loss of $0.50 per share and $315 million…
End-to-end multicloud technology services company Rackspace Technology entered the market with a whimper.
Novavax shares hit another all-time high on Wednesday after the company announced positive results from its early stage COVID-19 vaccine study.
Many see Apple stock going nowhere but up. See why Wamsi Mohan at BofA Securities has downgraded the stock but increased the price target.
Beyond Meat reported its most recent quarterly results after the markets closed on Tuesday, and shares retreated early Wednesday.
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be inexpensive…
Electric/hydrogen-powered truck builder Nikola reported a second-quarter net loss of $0.16 per share and $36,000 in revenue. Analysts were calling for a net loss of $0.13 per share and only $20,000 in revenue.
Disney posted a surprise $0.08 in earnings per share (EPS) and $11.78 billion in revenue in the second quarter. Analysts were expecting a net loss of $0.64 per share and $12.39 billion in revenue.
Yucaipa Acquisition is gearing up to come public as one of the newest special purpose acquisition companies. This one comes with a twist.
Regeneron Pharmaceuticals, one of the front-runners for the development of a COVID-19 treatment, released an update on its antibody drug combination on Monday.
Take-Two Interactive Software shares saw a bump early Tuesday after it reported mixed fiscal first-quarter financial results late on Monday.
Alterity Therapeutics stock more than doubled on Tuesday after the company announced new data for its lead drug candidate for the treatment of multiple system atrophy.
Amarin reported its latest quarterly results on Tuesday morning and gave an update on the most recent developments with its blockbuster drug Vascepa.
Google will invest $450 million in home and small business security firm ADT which will begin offering Google Nest products later this year.
Under Armour stock was crushed on Monday, despite receiving a relatively positive analyst upgrade.
